Centogene announces adoption of all resolutions tabled at 2024 annual general meeting

Cambridge, mass. and rostock, germany and berlin, may 31, 2024 (globe newswire) -- centogene n.v. (nasdaq: cntg) (the “company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the voting results of the company's 2024 annual general meeting. shareholders voted in favor of all proposals.
CNTG Ratings Summary
CNTG Quant Ranking